Scientists Design A PSA-activated Protoxin That Kills Prostate Cancer: Phase I Clinical Trial Is Under Way
13th Nov 2006, 08:27 GMT
Prague, Czech Republic: Scientists have found a way of using a protein madeby prostate cancer to target and kill the cancer cells themselves. Inpreliminary studies the new therapy affected only the prostate, withoutcausing damage to other healthy tissues, and now it is being tested in aphase I clinical trial. [click link for full article]
Scientists Design A PSA-activated Protoxin That Kills Prostate Cancer: Phase I Clinical Trial Is Under Way related news:
- Scientists Discover Way To Block Growth Of Prostate Cancer Cells — Health News from Medical News Today
- Elderly, ill men get unneeded prostate cancer screenings — EurekAlert! - Policy and Ethics
- Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up — Prostate Cancer and Prostatic Diseases
- 'Muscle' Protein Drives Prostate Cancer — Health News from Medical News Today
- Aeterna prostate cancer drug shows promise — Pharmaceutical Business Review Latest News
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma — Bio-Technology News from StratCenter.com
- Prostate-specific symptoms of prostate cancer in a German general population — Prostate Cancer and Prostatic Diseases
- Systemic Treatment Before Surgery For Kidney Cancer Prolongs Patients' Survival — Health News from Medical News Today
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer — PR Newswire: All Releases
- CuraGen, TopoTarget initiate ovarian cancer trial — Pharmaceutical Business Review Latest News
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes